Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

普托平 - NMPA Drug Approval Details

Approvals/NMPA/Lansoprazole Orally Disintegrating Tablets

Approved

化学药品

Lansoprazole Orally Disintegrating Tablets

TEVA TAKEDA YAKUHIN LTD.🇨🇳 National Medical Products Administration

Approval Date: Apr 16, 2020
Approval ID: 7MazXcRivly
Company: TEVA TAKEDA YAKUHIN LTD.
Type: 化学药品

Approval Details

Approval Id: 7MazXcRivly
Approval Number: H20120212
Generic Name: 兰索拉唑口崩片
Generic Name En: Lansoprazole Orally Disintegrating Tablets
Trade Name: 普托平
Brand Name: 普托平
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 30mg
Reg Date: 2020-04-16
Expired Date: 2023-11-01
Company Name: TEVA TAKEDA YAKUHIN LTD.
Company Address: 1-24-11,Taiko, Nakamura-ku,Nagoya-shi,Aichi,JAPAN
Production Company Name: kokando co.ltd. headquarters'plant
Production Company Address: 2-9-1,Umezawacho, Toyama City, Toyama, Japan
Company Detail Path: /organization/teva-takeda-yakuhin-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 16, 2020

Approval ID

7MazXcRivly

Type

化学药品

Back to NMPA Approvals